Jagsonpal
JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited Price (JAGSNPHARM.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
66,299,167
(1.2278)%Revenue and Profitability
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,500,939,872 | 1,361,976,157 | 1,395,934,054 | 1,609,549,785 | 1,765,139,000 | 1,664,645,000 | 1,438,509,000 | 1,381,509,000 | 1,434,879,000 | 1,438,704,000 | 1,265,329,000 | 1,668,256,000 | 1,585,678,000 | 1,878,756,000 | 2,260,967,000 | 2,367,141,000 | 2,087,020,000 |
| Net Income | 30,760,399 | 61,722,879 | 92,419,594 | 71,796,436 | 74,568,000 | 18,327,000 | 21,207,000 | 11,711,000 | 32,542,000 | 118,647,000 | -115,506,000 | 72,161,000 | 78,708,000 | 170,583,000 | 188,550,000 | 267,210,000 | 224,630,000 |
| FCF USD | 8,635,312 | 93,363,760 | -12,445,491 | -5,527,437 | 17,739,000 | 83,324,000 | 62,431,000 | 37,227,000 | 62,897,000 | -58,207,000 | -54,038,000 | 286,434,000 | 91,790,000 | 277,533,000 | 51,306,000 | 463,365,000 | 349,180,000 |
| OCF USD | 55,880,713 | 178,155,251 | 8,551,956 | 64,560,593 | 70,830,000 | 120,495,000 | 75,183,000 | 42,980,000 | 90,385,000 | -32,415,000 | -15,759,000 | 308,983,000 | 112,470,000 | 282,224,000 | 55,981,000 | 466,541,000 | 351,660,000 |
Financial Health - DEBT
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 2.83 | 0.44 | 0.57 | 0.04 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.34 |
| D/E | 0.54 | 0.35 | 0.23 | 0.31 | 0.35 | 0.34 | 0.36 | 0.41 | 0.39 | 0.07 | 0.08 | 0.04 | 0.04 | 0.06 | 0.00 | 0.04 | 0.05 |
| CA/CL | 6.73 | 5.74 | 5.70 | 6.67 | 1.70 | 1.73 | 1.70 | 1.74 | 1.76 | 3.74 | 3.31 | 3.46 | 2.89 | 2.98 | 3.24 | 5.97 | 10.42 |
| TA/TL | 2.36 | 2.88 | 3.46 | 3.12 | 2.71 | 2.80 | 2.71 | 2.62 | 2.61 | 4.36 | 4.09 | 4.34 | 4.09 | 3.88 | 4.48 | 5.41 | 7.31 |
| Total Debt | 403,813,541 | 279,658,368 | 202,790,892 | 285,938,739 | 348,935,000 | 334,070,000 | 359,575,000 | 393,105,000 | 384,927,000 | 79,281,000 | 83,005,000 | 37,854,000 | 46,648,000 | 67,879,000 | 0 | 60,013,000 | 89,410,000 |
Management Performance
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 2.12% | 5.58% | 8.33% | 4.85% | 5.26% | 1.19% | 1.53% | 0.85% | 2.32% | 9.80% | -10.09% | 5.99% | 5.13% | 11.22% | 12.81% | 15.47% | 8.08% |
| ROE | 4.10% | 7.70% | 10.55% | 7.73% | 7.57% | 1.86% | 2.15% | 1.23% | 3.31% | 10.79% | -11.78% | 6.91% | 7.09% | 13.99% | 14.41% | 16.82% | 11.99% |
| ROA | 0.00% | 8.06% | 8.52% | 6.78% | 4.78% | 1.20% | 1.62% | 1.08% | 2.56% | 10.10% | -8.96% | 6.63% | 6.41% | 13.32% | 16.22% | 17.86% | 10.35% |
| NM % | 2.05% | 4.53% | 6.62% | 4.46% | 4.22% | 1.10% | 1.47% | 0.85% | 2.27% | 8.25% | -9.13% | 4.33% | 4.96% | 9.08% | 8.34% | 11.29% | 10.76% |
| FCF / R% | 0.00% | 6.86% | -0.89% | -0.34% | 1.00% | 5.01% | 4.34% | 2.69% | 4.38% | -4.05% | -4.27% | 17.17% | 5.79% | 14.77% | 2.27% | 19.57% | 16.73% |
| FCF / NI% | 16.63% | 94.32% | -11.85% | -5.96% | 23.79% | 454.65% | 246.64% | 222.69% | 154.34% | -40.43% | 46.48% | 318.16% | 97.50% | 126.89% | 18.78% | 133.12% | 155.45% |
| Operating Margin (OM) | 0.00 | 0.13 | 0.17 | 0.17 | 0.18 | 0.19 | 0.22 | 0.53 | 0.25 | 0.32 | 0.27 | 0.25 | 0.30 | 0.31 | 0.30 | 0.40 | 0.50 |
Per Share
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.47 | 0.94 | 1.41 | 1.10 | 1.14 | 0.28 | 0.32 | 0.18 | 0.50 | 1.81 | -1.76 | 1.10 | 1.20 | 2.60 | 2.88 | 4.08 | 3.38 |
| SPS | 22.92 | 20.80 | 21.31 | 24.58 | 26.95 | 25.42 | 21.98 | 21.09 | 21.91 | 21.97 | 19.32 | 25.47 | 24.21 | 28.69 | 34.52 | 36.14 | 31.44 |
| OCPS | 0.85 | 2.72 | 0.13 | 0.99 | 1.08 | 1.84 | 1.15 | 0.66 | 1.38 | -0.49 | -0.24 | 4.72 | 1.72 | 4.31 | 0.85 | 7.12 | 5.30 |
| FCPS | 0.13 | 1.43 | -0.19 | -0.08 | 0.27 | 1.27 | 0.95 | 0.57 | 0.96 | -0.89 | -0.83 | 4.37 | 1.40 | 4.24 | 0.78 | 7.07 | 5.26 |
| BVPS | 11.46 | 12.24 | 13.37 | 14.19 | 15.03 | 15.02 | 15.06 | 14.57 | 15.02 | 16.78 | 14.97 | 15.95 | 16.95 | 18.62 | 19.98 | 24.26 | 28.23 |
Per Share - CAGR
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.47 | 0.94 | 1.41 | 1.10 | 1.14 | 0.28 | 0.32 | 0.18 | 0.50 | 1.81 | -1.76 | 1.10 | 1.20 | 2.60 | 2.88 | 4.08 | 3.38 |
| CAGR-SPS | 22.92 | 20.80 | 21.31 | 24.58 | 26.95 | 25.42 | 21.98 | 21.09 | 21.91 | 21.97 | 19.32 | 25.47 | 24.21 | 28.69 | 34.52 | 36.14 | 31.44 |
| CAGR-OCPS | 0.85 | 2.72 | 0.13 | 0.99 | 1.08 | 1.84 | 1.15 | 0.66 | 1.38 | -0.49 | -0.24 | 4.72 | 1.72 | 4.31 | 0.85 | 7.12 | 5.30 |
| CAGR-FCPS | 0.13 | 1.43 | -0.19 | -0.08 | 0.27 | 1.27 | 0.95 | 0.57 | 0.96 | -0.89 | -0.83 | 4.37 | 1.40 | 4.24 | 0.78 | 7.07 | 5.26 |
| CAGR-BVPS | 11.46 | 12.24 | 13.37 | 14.19 | 15.03 | 15.02 | 15.06 | 14.57 | 15.02 | 16.78 | 14.97 | 15.95 | 16.95 | 18.62 | 19.98 | 24.26 | 28.23 |